Sierra Oncology Inc

NASDAQ:SRRA  
23.18
+0.18 (+0.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Sierra Oncology Inc Stock, NASDAQ:SRRA

885 West Georgia Street, Suite 2150, Vancouver, British Columbia V6C 3E8
United States of America
Phone: +1.604.558.6536
Number of Employees: 69

Description

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.